Task: Answer the multiple choice question.
Question: Which compound exhibits a 6.035% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: Cc1ccc2c(c1)C(c1ccccc1)N(C(=O)c1cccc([N+](=O)[O-])c1)CC(=O)N2
b: Cc1ccc2cc(CCNC(=O)C3CCCC3)c(=O)[nH]c2c1
c: CCCn1c(SCc2nc3ccccc3s2)n[nH]c1=O
d: CC(C)Oc1ccc(C(=O)NN2C(=O)NC3(CCCCC3)C2=O)cc1
e: CCNc1ccc(C(=O)OCC(=O)NC(C)c2ccccc2)cc1[N+](=O)[O-]
Answer: b. Cc1ccc2cc(CCNC(=O)C3CCCC3)c(=O)[nH]c2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc2cc(CCNC(=O)C3CCCC3)c(=O)[nH]c2c1
Cc1ccc2cc(CCNC(=O)C3CCCC3)c(=O)[nH]c2c1
N-[2-(7-methyl-2-oxo-1H-quinolin-3-yl)ethyl]cyclopentanecarboxamide